Related Experiment Video
Updated: Apr 5, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
Current genome editing tools in gene therapy: new approaches to treat cancer
Oleg Shuvalov, Alexey Petukhov, Alexandra Daks
1Head of the Laboratory of Gene Expression Regulation, Institute of Cytology RAS, Saint-Petersburg, Tihkoretsky ave, 4, 194064, Russia. nick.a.barlev@gmail.com.
Abstract:
Gene therapy suggests a promising approach to treat genetic diseases by applying genes as pharmaceuticals. Cancer is a complex disease, which strongly depends on a particular genetic make-up and hence can be treated with gene therapy. From about 2,000 clinical trials carried out so far, more than 60% were cancer targeted. Development of precise and effective gene therapy approaches is intimately connected with achievements in the molecular biology techniques. The field of gene therapy was recently revolutionized by the introduction of "programmable" nucleases, including ZFNs, TALENs, and CRISPR, which target specific genomic loci with high efficacy and precision. Furthermore, when combined with DNA transposons for the delivery purposes into cells, these programmable nucleases represent a promising alternative to the conventional viral-mediated gene delivery. In addition to "programmable" nucleases, a new class of TALE- and CRISPR-based "artificial transcription effectors" has been developed to mediate precise regulation of specific genes. In sum, these new molecular tools may be used in a wide plethora of gene therapy strategies. This review highlights the current status of novel genome editing tools and discusses their suitability and perspectives in respect to cancer gene therapy studies.
Insights
Gene therapy, particularly using novel genome editing tools like CRISPR, offers a powerful strategy for treating genetic diseases, with over 60% of trials targeting cancer. These advanced molecular tools enhance precision and effectiveness in gene therapy applications.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Gene therapy is a promising approach for treating genetic diseases, with a significant focus on cancer treatment.
- Over 60% of the approximately 2,000 gene therapy clinical trials have targeted cancer.
- Advances in molecular biology techniques are crucial for developing effective gene therapy strategies.
Purpose of the Study:
- To review the current status of novel genome editing tools.
- To discuss the suitability and perspectives of these tools in cancer gene therapy.
- To highlight the impact of programmable nucleases and artificial transcription effectors.
Main Methods:
- Review of recent advancements in genome editing technologies.
- Analysis of programmable nucleases (ZFNs, TALENs, CRISPR) and their applications.
- Discussion of DNA transposons as non-viral delivery systems.
- Exploration of TALE- and CRISPR-based artificial transcription effectors for gene regulation.
Main Results:
- Programmable nucleases (ZFNs, TALENs, CRISPR) offer high precision and efficacy in targeting specific genomic loci.
- DNA transposons provide a promising alternative to viral vectors for gene delivery.
- Artificial transcription effectors enable precise regulation of gene expression.
- These tools have broad applicability in various gene therapy strategies.
Conclusions:
- Novel genome editing tools represent a significant advancement in gene therapy.
- Their precision and versatility hold great promise for the future of cancer gene therapy.
- Continued development of these molecular tools will drive innovation in treating genetic diseases.
Related Concept Videos
CRISPR
Gene Therapy
Gene Therapy
In-vitro Mutagenesis
What is Genetic Engineering?
CRISPR/Cas9 Genome Editing

